Skip to content

Respire Pink AT EF SPAT030USRecalls & reported problems

Respire Medical Holdings LLC · Intraoral appliance indicated to treat mild to moderate Obstructive Sleep Apnea (OSA) in patients, 18 years of age or older. · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00851861007253), received between Jan 25, 2023 and Jan 25, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Patient-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Patient-Device Incompatibility1

Patient problems

  • Hypersensitivity/Allergic reaction1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 25, 2023Patient-Device Incompatibility; Patient-Device Incompatibility

    THE PATIENT HAD AN ALLERGIC REACTION TO METAL HINGES, SPECIFICALLY BURNING SENSATION THAT TOOK 6 HOURS TO GO AWAY.

    Patient problems: Hypersensitivity/Allergic reaction

    MAUDE report 16242613 ↗

Other Device, Anti-Snoring devices

All Device, Anti-Snoring devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page